drugset / Trial / NCT03761784

A Study of S6G5T-3 in the Treatment of Acne Vulgaris

NCT03761784

Phase 3 Completed 424 enrolled Sol-Gel Technologies, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of S6G5T-3 compared to its Vehicle when applied once daily for 12 weeks in participants with acne vulgaris.

Timeline

Start
2018-12-21
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified Topical
Subject Tretinoin Small molecule Topical

Indications